Govt Job: For Ph.D, M.Pharm, M.Sc at AIIMS

The AIIMS, New Delhi model will be adopted and adapted. Unlike the Postgraduate Institutes which lack basic departments like Anatomy, Physiology, Pharmacology, General Medicine, Surgery, Obstetrics & Gynaecology, etc, the new AIIMS will have these departments as well as the super specialty departments like neurosurgery, cardiac surgery, urology, endocrinology, etc.

In addition, departments of Accident & Emergency, Biostatistics, Medical Engineering, Hospital administration, Genetics, Physical Medicine & Rehabilitation, Telemedicine, Clinical Epidemiology, and Medical Education Cell, etc are also planned.

This institution should also provide a good opportunity to promote basic scientists and biotechnologists and studies in genomics, proteomics, and metabonomics providing an opportunity to work in close proximity of rich clinical material.

Applications are invited from eligible candidates for contractual posts in a project titled Magnetoencephalography (MEG) Resource Facility, Department of Neuroscience, AIIMS New Delhi.

Scientist-III

Salary P.M: Rs. 78000+HRA

Max. Age: 45

Essential Qualification:  i) Post-Graduate Degree (MD/MS/DNB/MDS) after MBBS OR
ii) Post Graduate diploma in medical subjects after MBBS OR
iii) MBBS degree

Essential Experience:  i) Five years of experience
ii) Six years of experience
iii) 8 years experience in medical subjects after MBBS degree

Desirable: DM Neurology/MCH Neurosurgery

Research Associate-1

Salary P.M: Rs. 47000+HRA

Max. Age: 40

Essential Qualification : i) PhD/M D/MS/MDS or equivalent degree OR
ii) MVSc./M. Pharma/ME/M.Tech

Essential Experience:  i)  Nil
ii) 3 years of research teaching and design & development experience with at least one research paper in a science Citation indexed (SCI) journal.

Desirable: Working Experience with Molecular Neuroscience

Salary P.M: 35000+HRA

Max. Age: 35

Essential Qualification: i) M.Sc.(life Sciences), MA(Social Sciences), Master in Medical Social Work(MSW) degree holders. OR ii) MBBS / BDS / MVSc / M.Pharma / ME / M.Tech degree holders

Essential Experience :  (i) Two years of research experience (ii) Nil

Desirable: Experience in the field of Molecular Neuroscience

Interested candidates may send in their detailed resumes at projectrecruitment7003@gmail.com on or before 7th December 2022

Note :
• Service tenure will be till 26th March 2023.

• the Last date for resume submission with a post titled is 7th December 2022.

• If any candidate is interested to apply for various posts should submit a separate application/’esume with the post name for each post.

• Upper age relaxation for SC/ST up to 5 years and OBC up to 3 years for all categories. (Age relaxation for physically handicapped up to 10 years and 15 years for SC/ST, 13 years for OBC).

• No posts may vary and only shortlisted candidates will be called for the interview.

Related Posts

  • Pharma
  • July 22, 2025
  • 70 views
DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

  • Pharma
  • July 16, 2025
  • 479 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end